In a key development for Pakistan’s pharmaceutical sector, Haleon Pakistan Limited, formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited, has successfully exported Centrum—a ...
Shares of Haleon plc (NYSE:HLN – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the seven analysts that are presently covering the stock, MarketBeat.com reports.
Shares of HLN opened at $10.45 on Wednesday. Haleon has a 12 month low of $7.89 and a 12 month high of $10.80. The company has a 50-day moving average price of $9.66 and a two-hundred day moving ...
Pfizer sells entire Haleon stake for $3.24 billion Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional investors and the consumer ...
From left: Satheeskanth Sithambaram (Snr. Manager – Medical Marketing, Haleon Lanka), Harsha Ratnayake (Marketing Lead – Haleon Lanka), Manjula Weerakoon (Commercial Lead – Sri Lanka ...
Shares of Haleon PLC HLN rallied 4.18% to £3.98 Friday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.61% to 8,809.74.
Haleon Sri Lanka formerly known as GlaxoSmithKline Healthcare; the first multinational pharmaceutical manufacturing organization in Sri Lanka, which commenced manufacturing in 1956 with the flagship ...
In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against other stocks that lead Monday’s charge amid market bloodbath. The stock market kicked off the trading ...
British consumer healthcare group Haleon disappointed investors on Thursday after the Sensodyne toothpaste maker said 2025 revenue growth would be weighted to the second half of the year ...
Haleon plc misses on earnings expectations. Reported EPS is $0.05 EPS, expectations were $25.25. Jo Russell: Good morning, everyone. Welcome to Haleon’s Full Year 2024 Q&A call. I’m Jo Russell ...
GSK's consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion).
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...